In summary, we have observed contaminating NADH oxidation activity present in some MBP fusion proteins expressed in E. coli and purified by conventional amylose resin-based affinity chromatography. The contamination could be removed by either addition of 0.1% Triton X-100 and 2% glycerol in the homogenization and wash steps to the conventional purification system for MBP-fusion protein, or by Ni-NTA resin-based purification protocols if a His-tag is also engineered into the fusion proteins. It is possible that some MBP-fusion proteins may not bind well to amylose in the presence of this much detergent, in which case adding a His-tag to facilitate Ni-NTA resin-based purification protocol may be a better choice, or different concentrations of detergent may be tested to identify the best protein conditions. Because MBP fusion systems are commonly used to express foreign proteins in E. coli, and a large number of enzymes use NADH as a cofactor, it is necessary for the research community, particularly for those who study enzymes that use NADH as a cofactor, to be aware of this problem and the alternative protocols to eliminate any contamination.
We thank Drs. Haili Zhang and Xicheng Ding for technical assistance and Dr. S. Dean Rider for critical reading of the manuscript. This study was supported by grants from the National Institutes of Health (NIH), National Institute of Allergic and Infectious Diseases (NIAID; R01 AI44594 and R21 AI80022 to G.Z.). This paper is subject to the NIH Public Access Policy.
The authors declare no competing interests.
Address correspondence to Guan Zhu, Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, 4467 TAMU, College Station, TX, USA. e-mail: [email protected]
1.) Zerbs, S., A.M. Frank, and F.R. Collart. 2009. Bacterial systems for production of heterologous proteins. Methods Enzymol. 463:149-168. 2.) Fox, J.D., K.M. Routzahn, M.H. Bucher, and D.S. Waugh. 2003. Maltodextrin-binding proteins from diverse bacteria and archaea are potent solubility enhancers. FEBS Lett. 537:53-57. 3.) Sun, P.T.J., and DS. Waugh. 2011. Enhancing the solubility of recombinant proteins in Escherichia coli by using hexahistidine-tagged maltose-binding protein as a fusion partner. Methods Mol Biol. 705:259-274. 4.) Rider, S.D., and G. Zhu. 2008. Differential expression of the two distinct replication protein A subunits from Cryptosporidium parvum. J. CellBiochem. 104:2207-2216. 5.) Fritzler, J.M., and G. Zhu. 2007. Functional characterization of the acyl-[acyl carrier protein] ligase in the Cryptosporidium parvum giant polyketide synthase. Int. J Parasitol. 37:307-316. 6.) Fritzler, J.M., J.J. Millership, and G. Zhu. 2007. Cryptosporidium parvum long-chain fatty acid elongase. Eukaryot Cell 6:2018-2028. 7.) Zeng, B., X. Cai, and G. Zhu. 2006. Functional characterization of a fatty acyl-CoA-binding protein (ACBP) from the apicomplexan Cryptosporidium parvum. Microbiology 152:2355-2363. 8.) Zhu, G., Y. Li, X. Cai, J.J. Millership, M.J. Marchewka, and J.S. Keithly. 2004. Expression and functional characterization of a giant type I fatty acid synthase (CpFAS1) gene from Cryptosporidium parvum. Mol. Biochem Parasitol. 134:127-135. 9.) Madern, D., X. Cai, M.S. Abrahamsen, and G. Zhu. 2004. Evolution of Cryptosporidium parvum lactate dehydrogenase from malate dehydrogenase by a very recent event of gene duplication. Mol. Biol Evol. 21:489-497. 10.) Zhu, G., M.J. LaGier, F. Stejskal, J.J. Millership, X. Cai, and J.S. Keithly. 2002. Cryptosporidium parvum: the first protist known to encode a putative polyketide synthase. Gene 298:79-89. 11.) Zhu, G., M.J. Marchewka, K.M. Woods, S.J. Upton, and J.S. Keithly. 2000. Molecular analysis of a type I fatty acid synthase in Cryptosporidium parvum. PMol. Biochem arasitol. 105:253-260. 12.) Bergler, H., S. Fuchsbichler, G. Hogenauer, and F. Turnowsky. 1996. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA. Eur. J Biochem. 242:689-694. 13.) Freundlich, J.S., F. Wang, H.C. Tsai, M. Kuo, H.M. Shieh, J.W. Anderson, L.J. Nkrumah, J.C. Valderramos. 2007. X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy. J. Biol Chem. 282:25436-25444. 14.) Maity, K., T. Banerjee, N. Prabakaran, N. Surolia, A. Surolia, and K. Suguna. 2011. Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum. IUBMB Life 63:30-41. 15.) Dawson, R.B., D.C. Elliott, W.H. Elliott, and K.M. Janes. 1986. Data for Biochemical Research. Clarendon Press, Oxford. 16.) Schwarzer, D., H.D. Mootz, U. Linne, and M.A. Marahiel. 2002. Regeneration of misprimed nonribosomal peptide synthetases by type II thioesterases. Proc. Natl. Acad. Sci USA 99:14083-14088. 17.) Rial, D.V., and E.A. Ceccarelli. 2002. Removal of DnaK contamination during fusion protein purifications. Protein Expr Purif. 25:503-507. 18.) Ye, Z., and Y.H. Gan. 2007. Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. J. Biol Chem. 282:4479-4484.